News from expaTimes
Media Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top expaTimes News

GLP-1 · United StatesU.S. President Donald Trump announced agreements with pharmaceutical companies Novo Nordisk and Eli Lilly to reduce prices for their obesity drugs Wegovy and Zepbound, respectively, including $50 monthly copays for Medicare patients starting mid-2026 and expanded coverage for those with severe obesity.See the Story
Trump Announces Cost Cuts to Weight Loss Drugs
55% Center coverage: 284 sources



